Clinical Trial Update: Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing aprepitant to placebo for prevention of chemotherapy-induced nausea and vomiting in children and adolescents; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (Emend) (aprepitant)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Chemotherapy Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED